Edward Pershing insider trades

Open-market stock purchases and sales by Edward Pershing, CEO at Provectus Biopharmaceuticals, Inc, from SEC Form 4 filings since Jun 17, 2021.

Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -98%.

Recent trades

DateStockTradeValue
Jun 5, 2026PVCT Provectus Biopharmaceuticals, IncBought (not open market)—
May 28, 2026PVCT Provectus Biopharmaceuticals, IncBought (not open market)—
May 23, 2026PVCT Provectus Biopharmaceuticals, IncBought (not open market)—
May 15, 2026PVCT Provectus Biopharmaceuticals, IncBought (not open market)—
May 7, 2026PVCT Provectus Biopharmaceuticals, IncBought (not open market)—
Apr 29, 2026PVCT Provectus Biopharmaceuticals, IncBought (not open market)—
Apr 4, 2026PVCT Provectus Biopharmaceuticals, IncBought (not open market)—
Mar 25, 2026PVCT Provectus Biopharmaceuticals, IncBought (not open market)—
Mar 20, 2026PVCT Provectus Biopharmaceuticals, IncBought (not open market)—
Mar 12, 2026PVCT Provectus Biopharmaceuticals, IncBought (not open market)—
Mar 5, 2026PVCT Provectus Biopharmaceuticals, IncBought (not open market)—
Feb 26, 2026PVCT Provectus Biopharmaceuticals, IncBought (not open market)—
Feb 20, 2026PVCT Provectus Biopharmaceuticals, IncBought (not open market)—
Feb 19, 2026PVCT Provectus Biopharmaceuticals, IncBought (not open market)—
Feb 12, 2026PVCT Provectus Biopharmaceuticals, IncBought (not open market)—
Feb 9, 2026PVCT Provectus Biopharmaceuticals, IncBought$100K
Feb 5, 2026PVCT Provectus Biopharmaceuticals, IncBought (not open market)—
Jan 30, 2026PVCT Provectus Biopharmaceuticals, IncBought (not open market)—
Jan 28, 2026PVCT Provectus Biopharmaceuticals, IncBought (not open market)—
Jan 16, 2026PVCT Provectus Biopharmaceuticals, IncBought (not open market)—
Dec 11, 2025PVCT Provectus Biopharmaceuticals, IncBought (not open market)—
Dec 5, 2025PVCT Provectus Biopharmaceuticals, IncBought (not open market)—
Nov 26, 2025PVCT Provectus Biopharmaceuticals, IncBought (not open market)—
Nov 20, 2025PVCT Provectus Biopharmaceuticals, IncBought (not open market)—
Nov 13, 2025PVCT Provectus Biopharmaceuticals, IncBought (not open market)—

Companies traded

  • PVCT Provectus Biopharmaceuticals, Inc: 3 buys, last Jun 5, 2026

Get free alerts when Edward Pershing files a new trade →